Discover the complete record of transactions filed by 진홍국, Director. Officer active across 2 companies, notably 에이프릴바이오. Cumulatively, 17,943 filings have been logged. History available since 4 March 2026. The latest transaction was filed on 4 March 2026 (Purchase). Regulator: DART (FSS). All data is free.
Jin Hong-guk is a Director at 에이프릴바이오, a biotechnology company. In this role, he participates in strategic decision-making and oversees the company's projects. His expertise is valuable for developing new solutions.